Bausch Health Companies Inc.
Bausch Health Companies Inc. (BHC) is a diversified healthcare company with significant physician payment exposure ($16.9M in 2024 doctor payments) and a large insider buy cluster ($312.5M from Paulson entities in 180 days).
BusinessWhat BHC does
Bausch Health Companies Inc. operates as a diversified pharmaceutical and medical device company, with revenue lines spanning branded pharmaceuticals, over-the-counter products, medical aesthetics, and vision care through its Bausch + Lomb segment. The company markets products in dermatology, gastroenterology, eye health, and aesthetics. Its business model relies on a portfolio of branded products, including both patented and legacy brands.
12 months past · 3 months futureBHC activity timeline
Lifetime Government AwardsBHC federal contracts
BHC doesn't hold direct federal contracts.
Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.
Smart Money · 13F HoldingsHedge funds holding BHC
Congressional TradesWho in Congress is trading BHC
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
Stock awards & option exercises
Bills Affecting BHCLive legislation impacting this stock
Political ProfileWhere BHC sits in Washington
[object Object]
STRUCTURAL: High regulatory density (85) due to healthcare sector and physician payment scrutiny ($16.9M in 2024 doctor payments). EVIDENTIARY: Strong insider buy cluster: $312.5M from Paulson entities in 180 days per get_corporate_insider_signal and Recent corp insider Form 4 buys, including a $156.25M buy by PAULSON & CO. INC. on 2025-11-25. Net: Heavy insider accumulation offsets lack of political lobbying or donations.
Regulatory ExposureThreats & opportunities
Regulatory threats
-
Physician payment transparency and scrutiny under Open Payments programCMS (Centers for Medicare & Medicaid Services)"get_political_influence.doctor_payments shows $16.9M in total payments to 121,350 physicians in 2024 across subsidiaries."
-
Healthcare pricing and reimbursement legislationCongress, HHS"Recent bill_impacts array shows 8 healthcare bills with impact_ratios 0.0021-0.0023, each estimated revenue impact ~$4.9M-$5.1M."
Regulatory opportunities
-
Potential regulatory easing for drug approvals or medical devicesFDA"No direct evidence in data; but sector exposure suggests opportunity from legislative changes in healthcare bills."
Live signals + predictions for BHC — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades BHC
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord